Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PALATIN TECHNOLOGIES INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0
67.1
67.1
60.3
0.12
-0.19
1.47
4.85
4.49
0
Cost of revenue
0
0.15
0.22
0.42
0.1
Gross profit
0.12
-0.34
1.25
4.44
4.39
Research and development
43.1
32.6
32.6
14.9
14
12.9
21.3
22.6
22.4
14.9
Selling, general and administrative
16.5
15.3
12.3
7.81
General and administrative
6.18
8.64
8.64
9.7
9.77
17.3
16.5
Operating expenses
49.3
41.2
41.2
24.6
-23.6
33.2
38.1
37.3
27
17.5
Operating income
-49.3
25.9
25.9
35.7
-23.6
-33.4
-36.6
-32.5
-22.5
-17.5
Interest expense
2.51
1.45
1.45
0.42
0.02
0.02
0.03
0.02
0.02
0.02
Interest income
0.05
0.31
0.31
0.45
1.2
0.02
Other non-operating income
-2.46
-1.14
-1.14
0.03
1.18
-0.21
0.39
3.75
-7.24
0.15
Pre-tax income
-51.7
24.8
24.8
35.8
-22.4
-36.2
-32.2
Income tax
0
0.08
0.08
0
0
0
-4.67
0
Net income
-51.7
24.7
24.7
35.8
-22.4
-33.6
-36.2
-24
-29.7
-17.3
EBITDA
-49.2
26
26
35.8
-23.5
-33.3
-36.5
-32.2
-22.2
-17.2
EPS, basic
-16.53
6.01
6.01
8.51
-5.01
-7.01
-110.68
-2.02
EPS, diluted
-16.53
6.01
6.01
8.01
-5.01
-7.01
-110.68
-101.16
-32.15
Shares, basic (weighted)
3.13
3.96
3.96
4.15
4.69
4.73
0.22
14.7
Shares, diluted (weighted)
3.13
4.13
4.13
4.34
4.69
4.73
0.22
0.29
0.54
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
8
40.2
38
43.5
82.9
60.1
29.9
11
9.53
2.56
Short-term investments
0
2.99
0
Receivables
0
15.1
0
60.3
0
1.58
1.78
2.92
0
0
Inventory
0
1.16
0.94
0.53
0
Other current assets
1.31
1.01
0.51
0.64
0.74
3.06
1.93
1.9
0.24
0.33
Total current assets
10.7
56.6
38.5
104
83.6
65.9
34.6
16.3
9.77
2.92
Property, plant and equipment
0.1
0.2
0.16
0.14
0.14
0.09
0.54
0.68
0.39
0.13
Lease right-of-use assets
0
1.27
1.24
0.88
0.88
0.53
0.16
Other non-current assets
0.06
0.06
0.34
0.18
0.06
0.06
0.06
0.06
0.06
0.06
Total assets
10.9
56.8
39
105
85.1
67.3
36.1
17.9
10.7
3.27
Accounts payable
0.71
1.55
2.22
0.5
0.72
0.64
3.16
4.3
4.1
7
Accrued liabilities
7.77
10.5
2.1
2.85
2.9
5.8
6.88
6.51
4.19
0.88
Deferred revenue
35.1
0
Total current liabilities
13.9
55
10.8
4.19
3.93
10.5
16.3
15.1
9.66
8.01
Long-term debt
14.1
6.28
0.33
0.33
Lease liabilities
0
0.95
0.9
0.53
0.54
0.16
0.03
Other non-current liabilities
0.44
0.75
0.46
0
0
6.23
2.86
1.85
0
Total liabilities
28.4
62
12.1
4.19
4.88
17.6
19.8
19.7
10.9
8.04
Total debt
14.1
6.28
0.33
0.33
Paid-in capital
325
350
357
394
396
401
404
410
442
454
Retained earnings
-343
-357
-332
-296
-318
-352
-388
-412
-442
-459
Other comprehensive income
-0
-0
0
Shareholders' equity
-17.6
-5.16
27
101
80.2
49.7
16.3
-1.98
-0.11
-4.78
Total equity
-17.6
-5.16
27
101
80.2
49.7
16.3
-1.98
-0.11
-4.78
Total liabilities and equity
10.9
56.8
39
105
85.1
67.3
36.1
17.9
10.7
3.27
Shares outstanding
1.37
3.21
4
4.53
4.58
0.18
9.27
0.23
0.36
0.93
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-51.7
24.7
24.7
35.8
-22.4
-33.6
-36.2
-27.5
-29.7
-17.3
Depreciation and amortization
0.04
0.03
0.06
0.06
0.06
0.05
0.13
0.29
0.34
0.26
Stock-based compensation
1.84
1.76
3.52
3.48
3.14
3.17
2.51
1.67
1.87
1.38
Deferred income tax
0
0
-0.5
0
0
Change in receivables
0
15.1
-15.1
60.3
-60.3
-1.58
0.2
1.14
2.92
0
Change in inventory
-0.99
-0.22
-0.42
-1.15
0
Change in payables
-0.39
0.84
0.67
-1.72
0.21
-0.08
2.57
1.11
-0.2
2.9
Cash from operations
-47.4
12.9
1.7
-21.8
41.3
-0.09
-29.9
-29.3
-31.5
-21.3
Capital expenditures
-0.02
-0.13
-0.02
-0.04
-0.06
-0.01
-0.26
-0.43
-0.04
0
Purchases of investments
-1.39
0
0
0
-2.99
Sales and maturities of investments
0
2.99
0
Cash from investing
-1.4
0.99
0.23
-0.04
-0.06
-0.01
-0.26
-3.43
12.5
3.13
Debt issued
10
0
0
Stock issued
0
0.16
2.51
0.81
0
0
0
11
14.7
7.96
Cash from financing
29.5
18.3
-4.13
27.3
-1.92
-22.6
0.02
10.7
20.5
11.2
Net change in cash
-19.3
32.2
-2.2
5.51
39.3
-22.7
-30.2
-21.9
1.54
-6.96
Free cash flow
-47.4
12.7
1.68
-21.8
41.3
-0.1
-30.2
-29.7
-31.5
-21.3
Interest paid
1.84
1.68
1.08
0.35
0.02
0.02
0.03
0.02
0.02
0.02
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $10.10 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-50.7%
Operating income / revenue.
EBITDA margin
-49.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-48.6%
Net income / revenue.
Operating cash flow margin
-116.1%
Cash from operations / revenue.
Return on equity (ROE)
-59.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-47.3%
Net income / average total assets.
Return on invested capital (ROIC)
-1,191.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
95.9%
Research and development expense / revenue.
Stock-based pay / revenue
9.6%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
0.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-100.0%
Revenue vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-69.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-55.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-47.9%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
83.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-35.1%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.04x
Current assets / current liabilities.
Quick ratio
4.01x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
4.01x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$3.29
Revenue / diluted weighted shares.
Operating cash flow per share
-$3.82
Cash from operations / diluted weighted shares.
Book value per share
$5.96
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.40x
Market cap / revenue.
P/B
1.70x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.70x
Market cap / tangible book value, when positive.
EV/Sales
0.61x
Enterprise value / revenue.
Earnings yield
-34.8%
Net income / market cap (the inverse of P/E).
What was PALATIN TECHNOLOGIES INC's revenue in fiscal 2025?
PALATIN TECHNOLOGIES INC reported revenue of $0.0 for fiscal 2025, 100% lower than the year before.
Was PALATIN TECHNOLOGIES INC profitable in fiscal 2025?
No. It reported a net loss of $17.3M.
How much free cash flow did PALATIN TECHNOLOGIES INC generate in fiscal 2025?
Cash from operations of $21.3M minus capital expenditures of $0.0 left free cash flow of -$21.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.